Skip to content

Clinical trials

Active, not recruiting Carcinoma, Hepatocellular trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Active, not recruiting Country / region: Taiwan Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20172
20183
20194
20201
20211
20222
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
AbbVie3
National Health Research Institutes, Taiwan2
Bristol-Myers Squibb1
CStone Pharmaceuticals1
Chang Gung Memorial Hospital1
Chiayi Christian Hospital1
Chugai Pharmaceutical1
Coherus Oncology, Inc.1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular20
Liver Neoplasms5
Neoplasms4
Colorectal Neoplasms2
Biliary Tract Neoplasms1
Carcinoma1
Endometrial Neoplasms1
Neoplasm Metastasis1
Recurrence1
Squamous Cell Carcinoma of Head and Neck1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.